Novartis says "deep regret" over Japan drug trials scandal

TOKYO (Reuters) - The pharmaceutical head at Swiss firm Novartis AG apologized to the Japanese public for alleged manipulation of data in trials of its best-selling blood pressure drug Diovan, saying…
Read the full story: Reuters: Health News